Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32936265.
- Also identified by DOI 10.1001/jamacardio.2020.1738 and PMC identifier 7301295.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This economic evaluation study examines the authors’ experience of prescribing tafamidis in terms of their cost and the insurance status of patients.
Medical subject headings
- Benzoxazoles
- Cardiovascular Diseases
- Drug Prescriptions